Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:
A completed clinical trial evaluates a nomogram based on preoperative clinical characteristics and laboratory indicators to predict diagnose…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas [Phase 2]
A Phase 2 clinical trial evaluating injections of active allogeneic natural killer cells in patients with gliomas is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: [18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
Clinical trial update confirms completion of a study evaluating [18F]FPIA PET-CT imaging in glioblastoma.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
A clinical trial update describes ongoing Phase 1/2 studies evaluating super-selective intra-arterial repeated infusion of cetuximab for new…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM [Phase 1, Phase 2]
Clinical trial update announcing ongoing Phase 1/Phase 2 study of the CAPTEM regimen (capecitabine plus temozolomide) for newly diagnosed gl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) [Phase 1]
A Phase 1 clinical trial investigating a laparoscopically harvested omental autograft to bypass the blood-brain barrier in recurrent gliobla…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating repeated super-selective intraarterial infusion of bevacizumab (Avastin) for relapsed glioblastoma …
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours [Phase 1]
First-in-human Phase 1 trial of PhOx430, a first-in-class Acetylglucosaminyltransferase V inhibitor, assessed in advanced solid tumors; the …
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
This clinical trial update describes the development and implementation of an intervention aimed at enhancing involvement of relatives for p…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study [NA]
A proof-of-principle immuno-PET imaging study in glioblastoma, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma [Phase 3]
Phase 3 clinical trial evaluating dendritic cell-based immunotherapy for glioblastoma, currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors [Phase 1, Phase 2]
This clinical trial update describes evaluation of the PET tracer [18F]AlF-NOTA-PCP2 for PD-L1 detection across malignant tumors, including …
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Radioimmunotherapy with Lu-177 Labeled 6A10 Fab-fragments in Patients with Glioblastoma After Standard Treatment [Phase 1]
Phase 1 clinical trial evaluating Lu-177 labeled 6A10 Fab fragments for glioblastoma after standard treatment. The study is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma [Phase 2]
A Phase 2 trial (LUMINOS-101) evaluating Lerapolturev (PVSRIPO) in combination with pembrolizumab in recurrent glioblastoma has completed en…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma [Phase 2]
Phase 2 trial evaluating safety, pharmacokinetics, and efficacy of Paxalisib (GDC-0084) in newly diagnosed glioblastoma; trial completed wit…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) [NA]
This clinical trial update describes an ongoing study evaluating Laser Interstitial Thermal Therapy (LITT) followed by hypofractionated radi…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Tryptophan Metabolism in Human Brain Tumors-Novocure
This clinical trial update reports on a completed study examining tryptophan metabolism in human brain tumors, with a focus on glioblastoma.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Biomolecular Analysis for Predicting Response to Regorafenib [NA]
Completed clinical trial evaluating biomolecular markers to predict which glioblastoma patients respond to regorafenib, including the IDH-wi…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Patient's Derived Organoids for Drug Screening in Glioblastoma [NA]
The study aims to use patient-derived glioblastoma organoids to screen potential drugs, with the trial currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Modulation of Ciliogenesis in Glioma Stem Cells [NA]
This clinical trial update reports on a study investigating modulation of ciliogenesis in glioma stem cells for glioblastoma and malignant g…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas [Phase 1]
Phase I study of intratumoral GC001 in patients with recurrent or progressive high-grade gliomas is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma [NA]
This clinical trial registry entry describes a study applying stem cell analysis, multi-omics, and artificial intelligence to glioblastoma (…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating stereotactic photodynamic therapy with Gliolan (5-aminolevulinic acid) for adults with recurrent glioblastoma; the …
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects [Phase 1, Phase 2]
A Phase 1/2 study evaluating the GBM vaccine VBI-1901 for safety, tolerability, and dose optimization in recurrent glioblastoma is currently…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM) [Phase 1]
Phase 1 clinical trial evaluating BEY1107 in combination with temozolomide for recurrent or progressive glioblastoma multiforme; currently r…